Answer
Humira (adalimumab) is indicated for non-infectious intermediate, posterior and panuveitis in adults who have had an inadequate response to corticosteroids, need corticosteroid-sparing treatment, or for whom corticosteroid treatment is inappropriate.
Sources for this answer
- Humira 40 mg solution for injection in pre-filled pen (Great Britain)AbbVie Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 24Document updated
Sources checked